The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2014
DOI: 10.1002/alr.21381
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacotherapy for allergic rhinitis

Abstract: Pharmacotherapies for allergic rhinitis offer numerous options that are safe, effective, and readily available to target specific nasal symptoms. Symptom-based selection of allergy medications can result in optimal treatment for patients with allergic rhinitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
45
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(48 citation statements)
references
References 41 publications
(58 reference statements)
0
45
0
3
Order By: Relevance
“…Drugs for AR are reported to decrease salivary flow rate and play a role in the development of caries. 14,17 Second-generation antihistamines have less anticholinergic effects than first-generation antihistamines. The associated decrease in salivary flow is also less.…”
Section: Discussionmentioning
confidence: 99%
“…Drugs for AR are reported to decrease salivary flow rate and play a role in the development of caries. 14,17 Second-generation antihistamines have less anticholinergic effects than first-generation antihistamines. The associated decrease in salivary flow is also less.…”
Section: Discussionmentioning
confidence: 99%
“…Re‐exposure to specific antigens activates the sensitized mast cells; the mast cells then release chemical mediators, such as histamine, leukotrienes, serotonin, among others, to evoke AR clinical attacks . Although administration of histamine receptor antagonists or stabilizing mast cell membrane can satisfactorily inhibit AR symptoms, the therapeutic effects only last for a short time because this kind of treatment is only symptom control, it does not regulate the skewed Th2 polarization …”
Section: Introductionmentioning
confidence: 99%
“…Further support for a neurologic mechanism is that these conditions seem to be responsive to treatment with capsaicin or anticholinergic drugs. 3,67,68 Further endotypes of IR could be defined by the trigger type; for example, irritantsensitive IR. 8 An irritant-induced umbrella phenotype that includes not only IR but other entities such as occupational rhinitis subphenotypes has been proposed (see Fig.…”
Section: Idiopathic Rhinitismentioning
confidence: 99%